GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,862.50
-6.00 (-0.32%)
Oct 16, 2026, 5:15 PM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 74.63 billion as of October 16, 2026. It is the 233rd most valuable company in the world and the 9th biggest in the United Kingdom. Its market cap has increased by 13.95% in one year.
Market Cap
74.63B
Enterprise Value
89.35B
Revenue
33.20B
Global Rank
Country Rank
#9 United Kingdom
PE Ratio
15.86
ChartMarket Cap Chart
Since April 12, 2000, GSK plc's market cap has increased from 67.16B to 74.63B, an increase of 11.12%. That is a compound annual growth rate of 0.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 74.63B | 1.95% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 192.95B |
| Haleon | 32.58B |
| Smith & Nephew | 9.17B |
| Convatec Group | 4.66B |
| Hikma Pharmaceuticals | 3.42B |
| Oxford Nanopore Technologies | 2.01B |
| HUTCHMED (China) | 1.79B |
| Genus | 1.55B |